184 related articles for article (PubMed ID: 36998102)
1. Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.
Wang JB; Qiu QZ; Zheng QL; Zhao YJ; Xu Y; Zhang T; Wang SH; Wang Q; Jin QW; Ye YH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Yang YH; Zheng CH; Huang CM
Adv Sci (Weinh); 2023 May; 10(15):e2207417. PubMed ID: 36998102
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.
Wang JB; Gao YX; Ye YH; Zheng QL; Luo HY; Wang SH; Zhang T; Jin QW; Zheng CH; Li P; Lin JX; Chen QY; Cao LL; Yang YH; Huang CM; Xie JW
Theranostics; 2024; 14(7):2915-2933. PubMed ID: 38773976
[No Abstract] [Full Text] [Related]
3. A high interferon gamma signature of CD8
Li S; Li K; Tian F; Li H; Xia Q; Li T; Dong B; Li D; Yu J; Zhang J; Wang L; Zhang C; Xu S; Zhao Y; Liu Y
Front Immunol; 2022; 13():1056144. PubMed ID: 36685525
[TBL] [Abstract][Full Text] [Related]
4. Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures.
Han X; Lu H; Tang X; Zhao Y; Liu H
Immun Inflamm Dis; 2022 Jan; 10(1):43-59. PubMed ID: 34582114
[TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
7. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.
Wang G; Yang L; Wang Y; Hu R; Zhang K; Guo T; Chen B; Jiang X; Cui R
Front Immunol; 2022; 13():939836. PubMed ID: 35898512
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a TP53-associated immune prognostic model for gastric cancer.
Nie K; Zheng Z; Wen Y; Shi L; Xu S; Wang X; Zhou Y; Fu B; Li X; Deng Z; Pan J; Jiang X; Jiang K; Yan Y; Zhuang K; Huang W; Liu F; Li P
Genomics; 2020 Nov; 112(6):4788-4795. PubMed ID: 32858135
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer.
Liu Y; Li D; Chen Y; Liu Y; Lin Y; Huang X; Wu T; Wang C; Ding J
BMC Bioinformatics; 2023 May; 24(1):191. PubMed ID: 37161430
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
12. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
13. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
14. Development and verification of an immune-related gene prognostic index for gastric cancer.
Zhang C; Liu T; Wang J; Zhang J
Sci Rep; 2022 Sep; 12(1):15693. PubMed ID: 36127384
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
16. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
18. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
[TBL] [Abstract][Full Text] [Related]
19. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response.
Chen Y; Sun Z; Wan L; Chen H; Xi T; Jiang Y
Front Immunol; 2022; 13():890922. PubMed ID: 35572498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
